SNYRQ Synergy CHC Corp.

SNYRQ financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1562733 Exchange: OTC SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 10-Q filed May 14, 2026 Data checked: Oct 21, 2026
Showing 3 of 11 annual and 0 of 42 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$13.01M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
NV
Fiscal Year End
December (1231)
Phone
615-939-9004
EIN
990379440
Headquarters
WESTBROOK, ME, 04092
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Synergy Strips Corp. (2014–2015) · Oro Capital Corporation, Inc. (2012–2014)

▼ Key Metrics (TTM)

As of Mar 31, 2026
Financials
Revenue
$27.70M
Net Income
$-15.79M
Total Assets
$6.46M
Total Equity
$-25.41M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
65.4%
Operating Margin
-39.6%
Net Margin
-57%
Return on Equity
62.1%
Return on Assets
-244.3%
Current Ratio
0.93x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Synergy CHC Corp. recorded $30.38M of revenue, net loss of $12.34M, and an operating cash outflow of $2.59M. The $30.38M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 12.8% below fiscal 2024 revenue of $34.83M, marking a top-line contraction. The company reported diluted EPS of -$1.27, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $0.28 in fiscal 2024, the current result was 553.6% lower. Diluted shares averaged 9.72M; this is the reported share base over which the company’s diluted per-share earnings were spread. Total assets stood at $10.16M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 2.99x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $20.30M as gross profit before recognizing operating expenses and other items. Gross margin was 66.8%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $8.46M after the reported operating expense base. The operating loss equaled 27.8% of revenue, showing the scale of the operating deficit relative to sales. The bottom-line result was a net loss of $12.34M after operating, financing, tax, and other recognized items. Measured against revenue, the bottom-line deficit represented 40.6% after all recognized items. The company reported negative EBITDA of $8.33M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. Before income taxes, the company recorded a loss of $12.22M, bridging the operating result to the final net loss. Measured against revenue, the pretax deficit represented 40.2%. Income tax expense totaled $117.47K, providing the reported tax component that separates pretax and after-tax earnings. The net loss equaled 121.4% of period-end assets, showing the deficit relative to the asset base. The bottom line deteriorated from $2.12M of income in fiscal 2024 to a $12.34M loss.

Liquidity and Capital Structure

The company held $10.16M of assets against $33.29M of liabilities and -$23.13M of equity, revealing how the asset base was financed. Equity was negative at -$23.13M, meaning liabilities exceeded the residual book value available to shareholders and weakening balance-sheet resilience. The near-term balance sheet paired $10.01M of current assets with $8.24M of current liabilities at the reporting date. Current assets covered current liabilities by 1.22x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $2.62M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 31.8% of current liabilities, showing how much near-term coverage came from cash alone. Borrowings totaled $25.06M, adding a fixed financing obligation alongside the company’s equity capital. Debt represented 246.5% of total assets, placing borrowing in the context of the company’s full resource base. The equity-to-assets relationship was -227.5%, placing book capital against the total resource base. Relative to total assets, liabilities measured 327.5%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 25.8% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 37.8% lower than fiscal 2024 assets of $16.34M, measuring the company’s own balance-sheet change. Cash and equivalents were 281.2% higher than fiscal 2024 cash of $687.92K, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $2.59M of cash, resulting in an operating cash outflow for the year. The operating cash outflow narrowed to $2.59M from $4.80M in fiscal 2024.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Synergy CHC Corp.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $30.38M $34.83M $42.78M
Cost of Revenue $10.08M $11.19M $10.70M
Gross Profit $20.30M $23.64M $32.08M
OPERATING EXPENSES
SG&A Expense $8.83M $4.72M $6.05M
Operating Income $-8.46M $5.80M $10.81M
NON-OPERATING INCOME / EXPENSE
Interest Expense $1.96M $1.55M $1.69M
Interest Income $15.07K $1.52K $1.62K
Other Income/Expense $28.76M $17.84M $21.27M
Pretax Income $-12.22M $2.23M $6.57M
Income Tax $117.47K $102.09K $234.98K
Net Income $-12.34M $2.12M $6.34M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-1.27 $0.28 $0.86
Diluted Shares 9.72M 7.63M 7.37M
EBITDA $-8.33M $5.93M $10.84M
Depreciation & Amortization $133.33K $133.33K $33.33K
Balance Sheet
ASSETS
Cash & Equivalents $2.62M $687.92K $632.53K
Accounts Receivable $3.20M $5.32M $2.11M
Inventory $3.74M $1.72M $3.73M
Other Current Assets $351.05K $1.86M $797.99K
Current Assets $10.01M $16.06M $11.82M
Intangible Assets $150.00K $283.33K $416.67K
Noncurrent Assets $150.00K $283.33K $416.67K
Total Assets $10.16M $16.34M $12.24M
LIABILITIES
Accounts Payable $6.39M $5.19M $11.73M
Short-term Debt - $4.00M $2.09M
Other Current Liabilities (derived) - $7.99M $7.56K
Current Liabilities $8.24M $17.18M $14.02M
Long-term Debt $25.06M $7.46M $13.10M
Other Noncurrent Liabilities (derived) $0 $8.33M $12.43M
Noncurrent Liabilities $25.06M $15.79M $25.52M
Total Liabilities $33.29M $32.97M $39.55M
EQUITY
Common Stock $114 $87 $76
Additional Paid-in Capital $33.59M $27.64M $19.15M
Retained Earnings $-56.44M $-44.10M $-46.22M
Accumulated OCI $-154.28K $-47.78K $-102.47K
Total Equity $-23.13M $-16.63M $-27.31M
Total Liabilities & Equity $10.16M $16.34M $12.24M
SUPPLEMENTAL
Total Debt - $11.46M $15.19M
Shares Outstanding 11.30M 8.54M 7.37M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-2.59M $-4.80M $421.73K
Capital Expenditures - - -
Cash from Investing $0 $0 $0
Cash from Financing $4.65M $4.80M $-2.09M
Free Cash Flow - - -
Beginning Cash (CFS) $787.92K $732.53K $2.53M
Net Change in Cash $2.07M $696 $-1.67M
Effect of FX on Cash $-135.25K $54.69K $-124.86K
Calculated Ending Cash $2.72M $787.92K $732.53K
Cash per BS $2.62M $687.92K $632.53K
Cash scope difference (CFS − BS) $100.00K $100.00K $100.00K
Cash per CFS $2.72M $787.92K $732.53K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Synergy CHC Corp.'s annual revenue?

Synergy CHC Corp. reported $27.70M in revenue for trailing twelve months (ending March 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Synergy CHC Corp. profitable?

No. Synergy CHC Corp. reported $-15.79M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.